Regeneron Pharmaceuticals, Inc.REGNNASDAQ
Loading
Income Tax Expense Over TimeExpanding
Percentile Rank86
3Y CAGR+11.7%
5Y CAGR+19.6%
Year-over-Year Change
Income taxes paid or accrued
3Y CAGR
+11.7%/yr
vs +47.8%/yr prior
5Y CAGR
+19.6%/yr
Recent deceleration
Acceleration
-36.1pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
2.4x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $725.80M | +97.6% |
| 2024 | $367.30M | +49.5% |
| 2023 | $245.70M | -52.8% |
| 2022 | $520.40M | -58.4% |
| 2021 | $1.25B | +320.8% |
| 2020 | $297.20M | -5.1% |
| 2019 | $313.30M | +187.2% |
| 2018 | $109.10M | -87.6% |
| 2017 | $880.00M | +102.6% |
| 2016 | $434.29M | - |